{"id":"na-therapy","safety":{"commonSideEffects":[{"rate":"null","effect":"Allergic reactions"},{"rate":"null","effect":"Bleeding"},{"rate":"null","effect":"Infection"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"NA therapy is a process that involves removing or inactivating the abnormal red blood cells in the body. This is typically done through apheresis, a procedure that separates the blood into its different components and removes the abnormal red blood cells. The remaining blood components are then returned to the body.","oneSentence":"NA therapy works by removing or inactivating the abnormal red blood cells in the body.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:22:31.165Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hemolytic anemia"}]},"trialDetails":[{"nctId":"NCT06013722","phase":"NA","title":"Strategy for Unstable Coronary Plaque in Patients Presenting to Emergency Department for Chest Pain Suspected of Coronary Artery Disease","status":"RECRUITING","sponsor":"Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer","startDate":"2024-03-18","conditions":"Atherosclerosis","enrollment":250},{"nctId":"NCT03172975","phase":"PHASE2","title":"Efficacy of Na-GST-1/Alhydrogel Hookworm Vaccine Assessed by Controlled Challenge Infection","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2018-03-01","conditions":"Hookworm Infections","enrollment":39},{"nctId":"NCT06395467","phase":"NA","title":"Integrated Treatment for Enhancing Growth in Recovery During Adolescence","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2024-11-26","conditions":"Alcohol Use Disorder, Cannabis Use Disorder","enrollment":294},{"nctId":"NCT06247787","phase":"PHASE1","title":"A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2025-02-04","conditions":"Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Myelodysplastic Syndrome, Recurrent Juvenile Myelomonocytic Leukemia","enrollment":36},{"nctId":"NCT03866187","phase":"PHASE1, PHASE2","title":"Safety, Efficacy, Immunogenicity Study of GSK Biologicals' HBV Viral Vector and Adjuvanted Proteins Vaccine (GSK3528869A) in Adult Patients With Chronic Hepatitis B Infection","status":"TERMINATED","sponsor":"GlaxoSmithKline","startDate":"2019-03-28","conditions":"Hepatitis B, Chronic","enrollment":236},{"nctId":"NCT05419128","phase":"NA","title":"Family-focused vs. Drinker-focused Smartphone Interventions to Reduce Drinking-related Consequences of COVID-19","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2022-04-06","conditions":"Alcohol Use Disorder, Family Members, Behavior, Addictive","enrollment":398},{"nctId":"NCT07414095","phase":"","title":"Multidimensional Frailty Assessment and Post-Transplant Outcomes in Liver Transplant Candidates","status":"RECRUITING","sponsor":"Izmir Bakircay University","startDate":"2025-12-15","conditions":"End-Stage Liver Disease, Liver Transplantation, Cirrhosis","enrollment":60},{"nctId":"NCT06811363","phase":"","title":"Contribution of Bone to Urine Citrate","status":"ENROLLING_BY_INVITATION","sponsor":"University of Texas Southwestern Medical Center","startDate":"2026-02-28","conditions":"Osteoporosis","enrollment":25},{"nctId":"NCT06366230","phase":"PHASE1, PHASE2","title":"Adding Urea to the Final Dialysis Fluid","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2025-09-16","conditions":"Dysequilibrium Syndrome, ESRD, Hyperkalemia","enrollment":20},{"nctId":"NCT04431245","phase":"","title":"Stopping Antiviral Treatment in Chronic Hepatitis B","status":"ACTIVE_NOT_RECRUITING","sponsor":"The University of Hong Kong","startDate":"2021-06-01","conditions":"Chronic Hepatitis b","enrollment":54},{"nctId":"NCT03628209","phase":"PHASE1","title":"Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2019-10-03","conditions":"Osteosarcoma, Osteosarcoma in Children, Osteosarcoma Recurrent","enrollment":21},{"nctId":"NCT05594238","phase":"NA","title":"Leveraging Virtual Care Strategies to Improve Access and Treatment for Individuals With Alcohol Use Disorders","status":"RECRUITING","sponsor":"University of Michigan","startDate":"2023-08-07","conditions":"Alcohol Use Disorder","enrollment":400},{"nctId":"NCT07318181","phase":"NA","title":"Building Ukraine's Strength in PTSD Treatment and Research","status":"RECRUITING","sponsor":"University of Luxembourg","startDate":"2026-01-01","conditions":"Post Traumatic Stress Disorder, Post Traumatic Stress Disorder PTSD, Post-Traumatic Stress Disorder, PTSD","enrollment":120},{"nctId":"NCT01652092","phase":"NA","title":"Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies","status":"ACTIVE_NOT_RECRUITING","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2012-09-04","conditions":"SCID, Omenn's Syndrome, Reticular Dysgenesis","enrollment":57},{"nctId":"NCT07337369","phase":"NA","title":"Cultural Adaptation of CBTi for the Arab World","status":"COMPLETED","sponsor":"Laval University","startDate":"2022-09-01","conditions":"Insomnia Disorder, Insomnia, Cultural Adaptation","enrollment":54},{"nctId":"NCT07324434","phase":"PHASE1","title":"A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Oral F-02-2-Na Tablets in Adult Subjects","status":"ENROLLING_BY_INVITATION","sponsor":"Guangdong Hengqin Novagains Biopharmaceutical Co., Ltd.","startDate":"2025-12-15","conditions":"Hyperuricemia With or Without Gout","enrollment":69},{"nctId":"NCT07313878","phase":"NA","title":"Evaluation of Acute and Chronic Nephrotoxicity in Acute Lymphatic Leukemia Patients Using Ultrasound Localization Microscopy","status":"RECRUITING","sponsor":"University of Erlangen-Nürnberg Medical School","startDate":"2025-11-19","conditions":"Acute Lymphoblastic Leukaemias (ALL), Long Term Follow-Up","enrollment":30},{"nctId":"NCT05276297","phase":"PHASE2","title":"A Study on the Safety, Efficacy and Immune Response Following Sequential Treatment With an Anti-sense Oligonucleotide Against Chronic Hepatitis B (CHB) and Chronic Hepatitis B Targeted Immunotherapy (CHB-TI) in CHB Patients Receiving Nucleos(t)Ide Analogue (NA) Therapy","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2022-03-22","conditions":"Hepatitis B, Chronic","enrollment":174},{"nctId":"NCT07246889","phase":"PHASE3","title":"Study of AHB-137 in Participants With Chronic Hepatitis B (CHB) Treated With Nucleos(t)Ide Analogues (NAs)(AUSHINE)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ausper Biopharma Co., Ltd.","startDate":"2025-08-12","conditions":"Chronic Hepatitis B","enrollment":577},{"nctId":"NCT05761171","phase":"PHASE2","title":"A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2024-01-08","conditions":"Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia Due to Lineage Switch From Acute Leukemia of Ambiguous Lineage","enrollment":78},{"nctId":"NCT07167316","phase":"PHASE1","title":"The Role of the LC-NA System in Experimental Sleep Fragmentation","status":"NOT_YET_RECRUITING","sponsor":"Hans-Peter Landolt","startDate":"2026-01-05","conditions":"The Role of the LC-NA System in Sleep Regulation","enrollment":42},{"nctId":"NCT06341452","phase":"NA","title":"Comparison of Individualized Sodium Management Versus Standard Treatment in Hemodialysis","status":"RECRUITING","sponsor":"Fresenius Medical Care Deutschland GmbH","startDate":"2025-12-16","conditions":"End Stage Renal Disease","enrollment":130},{"nctId":"NCT07169110","phase":"","title":"Study of the Interprofessional Reproducibility of a Clinical Observation Scale for the Development of Very Premature Infants","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2025-12-22","conditions":"Prematurity","enrollment":35},{"nctId":"NCT07014618","phase":"","title":"Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer","status":"RECRUITING","sponsor":"University of Oklahoma","startDate":"2025-10-16","conditions":"Breast Cancer, Prostate Cancer","enrollment":420},{"nctId":"NCT02112916","phase":"PHASE3","title":"Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2014-10-04","conditions":"Adult T Acute Lymphoblastic Leukemia, Ann Arbor Stage II Adult Lymphoblastic Lymphoma, Ann Arbor Stage II Childhood Lymphoblastic Lymphoma","enrollment":847},{"nctId":"NCT04097860","phase":"NA","title":"Improving Lactation Success in Mothers of Critically Infants","status":"COMPLETED","sponsor":"University of Florida","startDate":"2020-12-01","conditions":"Breast Pumping","enrollment":122},{"nctId":"NCT02883049","phase":"PHASE3","title":"Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2012-02-29","conditions":"B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, Central Nervous System Leukemia","enrollment":5949},{"nctId":"NCT06550128","phase":"PHASE2","title":"Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB).","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ausper Biopharma Co., Ltd.","startDate":"2024-07-10","conditions":"Hepatitis B, Chronic","enrollment":86},{"nctId":"NCT06992843","phase":"NA","title":"Neuroprotection Bundles For Comatose Survivors Following Cardiac Arrest","status":"RECRUITING","sponsor":"Xiangya Hospital of Central South University","startDate":"2025-10-22","conditions":"Cardiac Arrest, Post-cardiac Arrest Care","enrollment":1008},{"nctId":"NCT04519879","phase":"PHASE2","title":"White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA","status":"ACTIVE_NOT_RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2021-05-10","conditions":"Prostate Adenocarcinoma, PSA Failure, PSA Progression","enrollment":133},{"nctId":"NCT04980482","phase":"PHASE2","title":"Open-Label Study of AB-729, Nucleos(t)Ide Analogue and Pegylated Interferon Alfa-2a in Subjects With Chronic Hepatitis B Infection","status":"COMPLETED","sponsor":"Arbutus Biopharma Corporation","startDate":"2021-10-29","conditions":"Chronic Hepatitis b","enrollment":43},{"nctId":"NCT05308264","phase":"PHASE1, PHASE2","title":"Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)","status":"RECRUITING","sponsor":"Rigel Pharmaceuticals","startDate":"2022-09-12","conditions":"Low Risk Myelodysplastic Syndromes","enrollment":86},{"nctId":"NCT04896255","phase":"","title":"Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B","status":"RECRUITING","sponsor":"Huashan Hospital","startDate":"2020-09-09","conditions":"Chronic Hepatitis b","enrollment":33000},{"nctId":"NCT05725057","phase":"PHASE1, PHASE2","title":"Proof of Concept Study of AX-158 in Patients With Mild to Moderate Plaque Psoriasis","status":"COMPLETED","sponsor":"Artax Biopharma Inc","startDate":"2023-11-30","conditions":"Psoriasis, Plaque Psoriasis","enrollment":31},{"nctId":"NCT07134972","phase":"NA","title":"The Effect of Ozone Treatment on Coronary Flow Reserve in Patients With Heart Failure Having Reduced Ejection Fraction","status":"COMPLETED","sponsor":"Ekrem Bilal Karaayvaz","startDate":"2024-01-14","conditions":"Heart Failure and Reduced Ejection Fraction","enrollment":60},{"nctId":"NCT04826692","phase":"PHASE3","title":"TEsting METformin Against Cognitive Decline in HD","status":"COMPLETED","sponsor":"Instituto de Investigacion Sanitaria La Fe","startDate":"2022-04-11","conditions":"Huntington Disease","enrollment":60},{"nctId":"NCT04912765","phase":"PHASE2","title":"Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC","status":"RECRUITING","sponsor":"National Cancer Centre, Singapore","startDate":"2021-04-15","conditions":"Hepatocellular Carcinoma, Hepatocellular Cancer, Colorectal Cancer","enrollment":60},{"nctId":"NCT04546399","phase":"PHASE2","title":"A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-12-17","conditions":"Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia","enrollment":461},{"nctId":"NCT06754943","phase":"PHASE1","title":"To Evaluate the Safety and PK Characteristics After Co-administration of JW0104 and C2402 and Administration of JW0105","status":"COMPLETED","sponsor":"JW Pharmaceutical","startDate":"2025-01-17","conditions":"Healthy","enrollment":60},{"nctId":"NCT04258332","phase":"NA","title":"CARDIA-Salt Sensitivity of Blood Pressure (SSBP)","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2021-05-17","conditions":"Salt Sensitivity of Blood Pressure, Hypertension","enrollment":281},{"nctId":"NCT07137910","phase":"PHASE2","title":"A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)","status":"NOT_YET_RECRUITING","sponsor":"Ausper Biopharma Co., Ltd.","startDate":"2025-08-27","conditions":"Chronic Hepatitis B","enrollment":60},{"nctId":"NCT05330455","phase":"PHASE1, PHASE2","title":"Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection","status":"ACTIVE_NOT_RECRUITING","sponsor":"GlaxoSmithKline","startDate":"2022-04-14","conditions":"Hepatitis B","enrollment":74},{"nctId":"NCT04177498","phase":"EARLY_PHASE1","title":"Rigosertib in Patients With Recessive Dystrophic Epidermolysis Bullosa Associated SCC","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2021-08-24","conditions":"Recessive Dystrophic Epidermolysis Bullosa","enrollment":3},{"nctId":"NCT07088133","phase":"NA","title":"Clinical Trials of the Hepatitis B Sandwich Combination Therapy for Treating Patients Infected With Hepatitis B Virus","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2025-08-01","conditions":"HBV Infection, HCC - Hepatocellular Carcinoma","enrollment":12},{"nctId":"NCT06537414","phase":"PHASE2","title":"A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)","status":"ACTIVE_NOT_RECRUITING","sponsor":"GlaxoSmithKline","startDate":"2024-11-11","conditions":"Chronic Hepatitis B Virus Infection, Hepatitis B","enrollment":283},{"nctId":"NCT07080645","phase":"NA","title":"BIOSILITACE AS A DESENSITIZING AGENTIN HMI","status":"NOT_YET_RECRUITING","sponsor":"University of Sao Paulo","startDate":"2025-07-30","conditions":"Sensitive Dentin, Hypomineralization Molar Incisor, Pain","enrollment":42},{"nctId":"NCT03557957","phase":"NA","title":"Targeted Correction of Plasma Sodium Levels in Hospitalized Patients With Hyponatremia","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2018-08-20","conditions":"Hyponatremia","enrollment":2278},{"nctId":"NCT07053722","phase":"","title":"Observational Clinical Study of Patients With Muscle - Invasive Bladder Cancer Undergoing Bladder Preservation Therapy After Neoadjuvant Therapy","status":"NOT_YET_RECRUITING","sponsor":"Peking University First Hospital","startDate":"2025-06-30","conditions":"Bladder (Urothelial, Transitional Cell) Cancer","enrollment":30},{"nctId":"NCT04026776","phase":"EARLY_PHASE1","title":"Uric Acid, Klotho and Salt Sensitivity in Young Adults Born Preterm","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2020-09-02","conditions":"Salt; Excess, Blood Pressure Disorders","enrollment":120},{"nctId":"NCT05550519","phase":"EARLY_PHASE1","title":"A Study in Chronic Hepatitis B e-Antigen Negative Participants After Discontinuation of Nucleos(t)Ide Analog (NA) Treatment","status":"WITHDRAWN","sponsor":"Janssen Pharmaceutica N.V., Belgium","startDate":"2022-10-31","conditions":"Hepatitis B, Chronic","enrollment":""},{"nctId":"NCT04439539","phase":"PHASE2","title":"A Study of JNJ-73763989, Pegylated Interferon Alpha-2a, Nucleos(t)Ide Analog (NA) With or Without JNJ-56136379 in Treatment-naive Participants With Hepatitis B e Antigen (HBeAg) Positive Chronic Hepatitis B Virus (HBV) Infection","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2020-09-14","conditions":"Hepatitis B, Chronic","enrollment":54},{"nctId":"NCT06744205","phase":"PHASE1, PHASE2","title":"A Study on the Safety and Immunogenicity of Hexavalent Influenza mRNA Vaccine in Adult Participants 50 Years of Age and Older","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2025-01-06","conditions":"Influenza, Healthy Volunteers","enrollment":1162},{"nctId":"NCT05123599","phase":"PHASE1","title":"A Study of JNJ-73763989, JNJ-64300535, and Nucleos(t)Ide Analogs in Virologically Suppressed, Hepatitis B e Antigen (HBeAg)- Negative Participants With Chronic Hepatitis B Virus Infection","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2021-12-06","conditions":"Hepatitis B, Chronic","enrollment":24},{"nctId":"NCT04585789","phase":"PHASE2","title":"A Study to Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Chronic Hepatitis B Virus Infection","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2021-03-11","conditions":"Hepatitis B","enrollment":24},{"nctId":"NCT06430320","phase":"","title":"Ascertaining Longterm Outcomes of Fibroid Treatments","status":"ENROLLING_BY_INVITATION","sponsor":"Henry Ford Health System","startDate":"2024-05-20","conditions":"Uterine Fibroid","enrollment":700},{"nctId":"NCT02331914","phase":"","title":"GIST: Assessment of Tumor Mutations and TKI Plasma Exposure","status":"COMPLETED","sponsor":"University Medical Center Groningen","startDate":"2014-12-08","conditions":"Gastro-intestinal Stromal Tumor","enrollment":740},{"nctId":"NCT04535544","phase":"PHASE2","title":"A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2020-09-17","conditions":"Hepatitis D, Chronic","enrollment":52},{"nctId":"NCT05275023","phase":"PHASE2","title":"An Efficacy and Safety Study of a Combination of JNJ-73763989, Nucleos(t)Ide Analogs (NA), and a Programmed Cell Death Protein Receptor-1 (PD-1) Inhibitor in Chronic Hepatitis B Participants","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2022-06-30","conditions":"Hepatitis B, Chronic","enrollment":37},{"nctId":"NCT04954859","phase":"PHASE2","title":"Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure)","status":"RECRUITING","sponsor":"GlaxoSmithKline","startDate":"2021-12-14","conditions":"Hepatitis B","enrollment":450},{"nctId":"NCT06650267","phase":"PHASE2","title":"Substance Misuse and Family Violence Treatment Fathers","status":"RECRUITING","sponsor":"Yale University","startDate":"2025-02-17","conditions":"Substance Misuse, Violence, Domestic, Child Abuse","enrollment":280},{"nctId":"NCT05074030","phase":"NA","title":"EMA/EMI for Psychiatrically Hospitalized Emerging Adults Who Drink to Cope","status":"ACTIVE_NOT_RECRUITING","sponsor":"Butler Hospital","startDate":"2023-02-06","conditions":"Alcohol Use Disorder","enrollment":60},{"nctId":"NCT05976672","phase":"NA","title":"Machine Learning Technology in Predicting Relapse and Implementing Peer Recovery Intervention Before Drug Use Occurs","status":"ACTIVE_NOT_RECRUITING","sponsor":"West Virginia University","startDate":"2023-04-27","conditions":"Substance Abuse Disorder","enrollment":500},{"nctId":"NCT06145997","phase":"","title":"Feasibility and Acceptability Study of ACUAWARE","status":"TERMINATED","sponsor":"University of Utah","startDate":"2023-12-15","conditions":"Chronic Pain","enrollment":1},{"nctId":"NCT06263959","phase":"PHASE2","title":"A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B","status":"RECRUITING","sponsor":"Fujian Akeylink Biotechnology Co., Ltd.","startDate":"2023-12-26","conditions":"Chronic Hepatitis B","enrollment":45},{"nctId":"NCT02828358","phase":"PHASE2","title":"Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2017-04-01","conditions":"Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia","enrollment":78},{"nctId":"NCT03296202","phase":"","title":"Risk of Morbidity, Mortality and Long-term Monitoring of Antiretroviral Treatment in People Living With HIV","status":"RECRUITING","sponsor":"University Hospital, Bordeaux","startDate":"2017-07-18","conditions":"HIV Infections, Antiretroviral Agents","enrollment":7200},{"nctId":"NCT04129554","phase":"PHASE2","title":"A Study of JNJ 73763989+JNJ 56136379+Nucleos(t)Ide Analog (NA) Regimen Compared to NA Alone in e Antigen Negative Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection","status":"COMPLETED","sponsor":"Janssen Sciences Ireland UC","startDate":"2019-11-06","conditions":"Hepatitis B, Chronic","enrollment":130},{"nctId":"NCT03982186","phase":"PHASE2","title":"A Study of Different Combination Regimens Including JNJ-73763989 and/or JNJ-56136379 for the Treatment of Chronic Hepatitis B Virus Infection","status":"COMPLETED","sponsor":"Janssen Sciences Ireland UC","startDate":"2019-08-01","conditions":"Hepatitis B, Chronic","enrollment":471},{"nctId":"NCT05423106","phase":"PHASE1","title":"A Single and Multiple Ascending Dose Study of JNJ-64457744","status":"TERMINATED","sponsor":"Janssen Research & Development, LLC","startDate":"2022-07-04","conditions":"Healthy, Hepatitis B, Chronic","enrollment":60},{"nctId":"NCT06778824","phase":"NA","title":"Neuroregulators for the Treatment of Diseases Associated With Esophageal-brain-gut Axis Communication Abnormalities.","status":"RECRUITING","sponsor":"Hualien Tzu Chi General Hospital","startDate":"2024-04-02","conditions":"Gut-Brain Disorders, GERD Without Erosive Esophagitis","enrollment":610},{"nctId":"NCT06777173","phase":"NA","title":"Clinical Study of Antiviral Therapy Combined With Novel Immunotherapy for CHB in Adults","status":"ENROLLING_BY_INVITATION","sponsor":"Beijing Ditan Hospital","startDate":"2023-12-01","conditions":"Chronic Hepatitis b, Immunotherapy","enrollment":180},{"nctId":"NCT06746701","phase":"","title":"Study on the Treatment of Hepatitis B Virus(HBV) Infected Individuals With Peginterferon α-2b Combined With NA.","status":"RECRUITING","sponsor":"Xiangya Hospital of Central South University","startDate":"2023-05-25","conditions":"HBV","enrollment":400},{"nctId":"NCT06709911","phase":"NA","title":"A Comparative Study of the Efficacy of Multimodal Interventions for Tenosynovitis","status":"NOT_YET_RECRUITING","sponsor":"Zixin Deng","startDate":"2024-12-01","conditions":"TGCT","enrollment":45},{"nctId":"NCT06047093","phase":"NA","title":"Fine Needle Aspiration (FNA) Evaluation of the Intrahepatic HBV Reservoir and Its Immunological Characteristics in Chronically HBV-infected Patients","status":"RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2024-03-08","conditions":"Chronic Hepatitis b","enrollment":100},{"nctId":"NCT04882215","phase":"NA","title":"Integrated PRocess and StrategieS Training: I-PRESS Training","status":"TERMINATED","sponsor":"NHS Greater Glasgow and Clyde","startDate":"2020-05-18","conditions":"Acquired Brain Injury","enrollment":14},{"nctId":"NCT06683430","phase":"NA","title":"High Potassium Diet with Spices and Herbs As Salt Substitute for Lowering Blood Pressure in Older Adults: Study Protocol","status":"COMPLETED","sponsor":"Universitas Airlangga","startDate":"2022-05-11","conditions":"Hypertension, Older Adults Institutionalized in Residential Homes","enrollment":62},{"nctId":"NCT06676410","phase":"PHASE2","title":"Clinical Trial to Evaluate the Efficacy and Safety of Codivir® in Addition to Standard Antiretroviral Treatment for HIV Infection in Antiretroviral-naïve Participants","status":"RECRUITING","sponsor":"Code Pharma","startDate":"2023-07-20","conditions":"HIV, HIV Infection","enrollment":40},{"nctId":"NCT06671132","phase":"PHASE2","title":"Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Networks Training for Treatment of Pain (CBOT-P)","status":"RECRUITING","sponsor":"Evon Medics LLC","startDate":"2024-10-23","conditions":"Chronic Pain, Low Back Pain","enrollment":220},{"nctId":"NCT06612359","phase":"PHASE1","title":"Impact of the BOOST GAIT Program on Gait Recovery and Functional Mobility After Stroke","status":"RECRUITING","sponsor":"Hasselt University","startDate":"2024-09-02","conditions":"Stroke with Hemiparesis, Stroke","enrollment":12},{"nctId":"NCT04521790","phase":"","title":"Role of Endomyocardial Biopsy and Aetiology-based Treatment in Patients With Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management","status":"RECRUITING","sponsor":"Scientific Institute San Raffaele","startDate":"2018-01-30","conditions":"Myocarditis, Ventricular Arrythmia, Inflammatory Cardiomyopathy","enrollment":1000},{"nctId":"NCT06591260","phase":"","title":"Role of Endomyocardial Biopsy and Aetiology-based Treatment in Pediatric Patients with Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management (MYOPED)","status":"RECRUITING","sponsor":"Scientific Institute San Raffaele","startDate":"2013-01-01","conditions":"Myocarditis, Ventricular Arrhythmia, Inflammatory Cardiomyopathy","enrollment":20},{"nctId":"NCT06525909","phase":"","title":"A Real-world Study of Staging and Grading of Clinical Immune Status in Chronic Hepatitis B","status":"RECRUITING","sponsor":"Tongji Hospital","startDate":"2024-01-20","conditions":"Hepatitis B, Chronic","enrollment":250},{"nctId":"NCT04667104","phase":"PHASE2","title":"A Study of JNJ-73763989, JNJ-56136379, Nucleos(t)Ide Analogs, and Pegylated Interferon Alpha-2a in Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2021-02-01","conditions":"Hepatitis B, Chronic","enrollment":48},{"nctId":"NCT03362970","phase":"NA","title":"Improvements Through the Use of a Rapid Multiplex PCR Enteric Pathogen Detection Kit in Children With Hematochezia","status":"COMPLETED","sponsor":"University of Calgary","startDate":"2018-06-15","conditions":"Diarrhea Bloody","enrollment":60},{"nctId":"NCT06457477","phase":"NA","title":"Sequential Combination Therapy With PD-1 Antibody and Peg-IFNα in CHB Patients","status":"RECRUITING","sponsor":"Beijing 302 Hospital","startDate":"2024-06-15","conditions":"Chronic Hepatitis B","enrollment":50},{"nctId":"NCT06403293","phase":"NA","title":"Influence of Sonic Activation of Root Sealers on Post-Operative Pain","status":"COMPLETED","sponsor":"Mustafa Kemal University","startDate":"2023-01-16","conditions":"Post Operative Pain, Apical Periodontitis","enrollment":120},{"nctId":"NCT06066671","phase":"NA","title":"The Effect of an Experimental Gel Based on Copaiba Oil Resin in Reducing Post-bleaching Tooth Sensitivity","status":"COMPLETED","sponsor":"Universidade Federal do Para","startDate":"2024-01-10","conditions":"Tooth Bleaching Pain","enrollment":75},{"nctId":"NCT04676724","phase":"PHASE2","title":"Study of Sequential GSK3228836 and Peginterferon Treatment in Participants With Chronic Hepatitis B (CHB)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2021-01-28","conditions":"Hepatitis B","enrollment":108},{"nctId":"NCT06386926","phase":"NA","title":"Radial Shockwave Versus Ultrasound Phonophoresis","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2024-05-01","conditions":"Supraspinatus Tendinitis","enrollment":69},{"nctId":"NCT06270030","phase":"PHASE1","title":"Safety, Tolerability and Pharmacokinetics of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Chinese With Presbyopia","status":"COMPLETED","sponsor":"Corxel Pharmaceuticals","startDate":"2024-03-04","conditions":"Presbyopia","enrollment":21},{"nctId":"NCT05808972","phase":"PHASE4","title":"0.9% Saline Versus Balanced Solutions in Severe Diabetic Ketoacidosis","status":"COMPLETED","sponsor":"Tunis University","startDate":"2022-11-01","conditions":"Metabolic Ketoacidosis, Ketoacidemia, Acetonemia","enrollment":92},{"nctId":"NCT06361004","phase":"NA","title":"Exploring DBS Efficacy in Treatment-refractory Tourette's Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2024-04-20","conditions":"Tourette's Syndrome","enrollment":60},{"nctId":"NCT05619120","phase":"NA","title":"The Effect of Late Na Current Blocker Mexiletine on Giant T-wave Electrical Alternans(STOP-TWA)","status":"RECRUITING","sponsor":"First Affiliated Hospital Xi'an Jiaotong University","startDate":"2023-01-01","conditions":"Giant T-wave Electrical Alternans","enrollment":50},{"nctId":"NCT05005507","phase":"PHASE2","title":"A Study of JNJ-73763989, Pegylated Interferon Alpha-2a and Nucleos(t)Ide Analogs in Participants With Chronic Hepatitis B Virus Infection","status":"TERMINATED","sponsor":"Janssen Research & Development, LLC","startDate":"2021-11-03","conditions":"Hepatitis B, Chronic","enrollment":1},{"nctId":"NCT06251414","phase":"NA","title":"Study on the Effect of Exercise Intervention Combined With Physical Therapy on Chronic Ankle Instability Symptoms","status":"COMPLETED","sponsor":"Yang Liu","startDate":"2023-11-20","conditions":"Chronic Ankle Instability,CA","enrollment":45},{"nctId":"NCT06196632","phase":"","title":"Development and Validation of Models to Predict Functional Cure in Patients With CHB After Peg-IFN Based Therapy","status":"UNKNOWN","sponsor":"Qilu Hospital of Shandong University","startDate":"2024-01-06","conditions":"Hepatitis B, Chronic","enrollment":1000},{"nctId":"NCT06218407","phase":"PHASE1","title":"Development and Evaluation of Computerized Chemosensory Based Orbitofrontal Networks Training for Treatment of Pain","status":"COMPLETED","sponsor":"Evon Medics LLC","startDate":"2023-04-27","conditions":"Chronic Pain, Low Back Pain","enrollment":86},{"nctId":"NCT06198647","phase":"NA","title":"Manual Therapy for Pregnancy Related Back Pain","status":"UNKNOWN","sponsor":"Benha University","startDate":"2024-01-15","conditions":"Low Back Pain","enrollment":40},{"nctId":"NCT03562845","phase":"","title":"Evaluation of Immunobiogram® as a Tool in Adjustment of Immunosuppressant Therapy for Renal Transplant","status":"COMPLETED","sponsor":"Biohope Scientific Solutions for Human Health, S.L.","startDate":"2018-06-01","conditions":"Kidney Transplantation","enrollment":164},{"nctId":"NCT00716976","phase":"PHASE3","title":"Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2008-06-23","conditions":"Brain Tumor, Central Nervous System Tumor, Childhood Germ Cell Tumor","enrollment":131}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":374,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"NA therapy","genericName":"NA therapy","companyName":"GlaxoSmithKline","companyId":"glaxosmithkline","modality":"Small molecule","firstApprovalDate":"","aiSummary":"NA therapy works by removing or inactivating the abnormal red blood cells in the body. Used for Hemolytic anemia.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}